MM-119: Updated Results of Ciltacabtagene Autoleucel (Cilta-Cel), a B-Cell Maturation Antigen (BCMA)-Directed Chimeric Antigen Receptor T (CAR-T) Cell Therapy in Relapsed/Refractory Multiple Myeloma (RRMM).
- Resource Type
- Article
- Authors
- Usmani, Saad Z.; Berdeja, Jesus G.; Madduri, Deepu; Jakubowiak, Andrzej; Agha, Mounzer; Cohen, Adam D.; Hari, Parameswaran; Yeh, Tzu-Min; Olyslager, Yunsi; Banerjee, Arnob; Jackson, Carolyn C; Allred, Alicia; Zudaire, Enrique; Deraedt, William; Wu, Xiaoling; Carrasco-Alfonso, Marlene J.; Akram, Muhammad; Lin, Yi; Martin, Thomas; Jagannath, Sundar
- Source
- Clinical Lymphoma, Myeloma & Leukemia; 2021 Supplement 1, Vol. 21, pS422-S423, 2p
- Subject
- Language
- ISSN
- 21522650